Serum biomarkers for antiresorptives-related osteonecrosis of the jaw: In vivo and clinical validation studies

Serum biomarkers for antiresorptives-related osteonecrosis of the jaw: In vivo and clinical validation studies

Bibliographic Details
Main Authors:	Hye-Yeon Kim, Jinwoo Kim
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	Bone Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352187220304290

Similar Items

Antiresorptive agent-related osteonecrosis of the jaw in osteoporosis patients from Asian countries
by: Akira Taguchi, et al.
Published: (2017-06-01)

Knowledge and clinical behavior on antiresorptive medications and osteonecrosis of the jaws: a cross-sectional study
by: Daniel Amaral Alves MARLIÉRE, et al.
Published: (2019-12-01)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)
by: Akira Baba, et al.
Published: (2019-11-01)

Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents
by: Lukas Hauer, et al.
Published: (2020-03-01)

Prognosis of medication-related osteonecrosis of the jaws in cancer patients using antiresorptive agent zoledronic acid
by: Ling-Ying Wei, et al.
Published: (2021-08-01)

Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature
by: Kununya Pimolbutr, et al.
Published: (2018-01-01)

The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review
by: Roberto Sacco, et al.
Published: (2021-01-01)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage.
by: Takuma Watanabe, et al.
Published: (2021-01-01)

Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage
by: Watanabe, Takuma
Published: (2021)

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?
by: Giacomo Oteri, et al.
Published: (2018-01-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): Are Antiresorptive Drugs the Main Culprits or Only Accomplices? The Triggering Role of Vitamin D Deficiency
by: Luca Dalle Carbonare, et al.
Published: (2021-02-01)

Early Detection of Antiresorptive drug-Related Osteonecrosis of the Jaws (ARONJ) with Technetium-99m Methylene Diphosphonate-based Bone Scintigraphy
by: Anna Marie J. Miranda, et al.
Published: (2015)

Pharmacoepidemiology and clinical characteristics of medication-related osteonecrosis of the jaw
by: Hyo-Jeong Son, et al.
Published: (2019-07-01)

Intraoral localized methotrexate‐associated lymphoproliferative disorders concurrent with antiresorptive agent‐related osteonecrosis of the jaw: A case report and literature review
by: Masaki Minabe, et al.
Published: (2020-12-01)

Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
by: Camilla Ottesen, et al.
Published: (2020-04-01)

Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience
by: Gianfranco Favia, et al.
Published: (2016-01-01)

The risk of osteonecrosis of the jaw and adverse outcomes in patients using antiresorptive drugs undergoing orthodontic treatment: A systematic review
by: Julian Woolley, et al.
Published: (2021-01-01)

Clinical study of bisphosphonate⁃related osteonecrosis of the jaws
by: WU Yu⁃ling, et al.
Published: (2017-01-01)

Fatal infectious encephalitis as a complication of medication-related osteonecrosis of the jaw
by: Hye-Won Kim, et al.
Published: (2020-09-01)

Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
by: Acquavella J, et al.
Published: (2016-07-01)

Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018-08-01)

Osteonecrosis of the jaw among patients receiving antiresorptive medication: A 4-year retrospective study at a tertiary cancer center, Kerala, India
by: Pramod S Sankar, et al.
Published: (2018-01-01)

Clinical diagnosis and treatment on bisphosphonate⁃related osteonecrosis of the jaw
by: YIN Xue⁃min, et al.
Published: (2017-03-01)

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
by: Vincenzi Bruno, et al.
Published: (2012-09-01)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
by: Yong-Dae Kwon, et al.
Published: (2016-11-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)

Bisphosphonate-related osteonecrosis of the jaw: An insight
by: Shalini Kapoor, et al.
Published: (2013-01-01)

Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012-01-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW AND DENTAL IMPLANTS
by: Ala Hassan A. Qamheya, et al.
Published: (2016-01-01)

Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
by: Andrea Cassoni, et al.
Published: (2016-01-01)

Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw
by: Yoshimasa Kitagawa, et al.
Published: (2019-11-01)

Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws
by: Li-Wan Lee, et al.
Published: (2014-03-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Rajiv S Desai, et al.
Published: (2012-01-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

Osteonecrosis of the jaw in association to bisphosphonates
by: Mattos, Ana Carolina Lopes
Published: (2020)

The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma
by: Shin-Yu Lu, et al.
Published: (2021-11-01)

Concentration of Penicillin G in Jawbone Affected by Antiresorptive Agent-Related Osteonecrosis Following a Single Preoperative Dose
by: Philipp Poxleitner, et al.
Published: (2021-12-01)

Bisphosphonates-induced osteonecrosis of the jaw: pharmacology and clinical procedures.
by: Candice Belchior Duplat, et al.
Published: (2012-01-01)

BISPHOSPHONATES-INDUCED OSTEONECROSIS OF THE JAW: PHARMACOLOGY AND CLINICAL PROCEDURES.
by: Candice Belchior Duplat, et al.
Published: (2012-08-01)

Cannot write session to /tmp/vufind_sessions/sess_39sim6eft8f780u4jahh2jrq2m